ReviewCurrent hematologic malignancy reports2026
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia.
Zuhal Naderi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewCurrent hematologic malignancy reports2026
Zuhal Naderi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.